|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 858.80 INR | +1.78% |
|
+6.16% | +5.87% |
| Market Cap | 840M 8.71M 7.64M 7.06M 6.49M 12.25M 12.44M 84.39M 33.08M 411M 32.71M 32M 1.42B | P/E 2024 |
17.7x | P/E 2025 | 31.3x |
|---|---|---|---|---|---|
| Enterprise Value | 879M 9.11M 7.99M 7.38M 6.79M 12.81M 13.02M 88.3M 34.61M 430M 34.23M 33.48M 1.48B | EV / Sales 2024 |
1.29x | EV / Sales 2025 | 1.36x |
| Free-Float |
13.68% | Yield 2024 |
0.42% | Yield 2025 | 0.43% |
| 1 day | +1.78% | ||
| 1 week | +6.16% | ||
| Current month | +9.16% | ||
| 1 month | +0.95% | ||
| 3 months | +13.59% | ||
| 6 months | +7.35% | ||
| Current year | +5.87% |
| 1 week | 767 | 901.9 | |
| 1 month | 714.7 | 901.9 | |
| Current year | 620.55 | 928.5 | |
| 1 year | 620.55 | 976 | |
| 3 years | 620.55 | 1,303 | |
| 5 years | 390 | 1,303 | |
| 10 years | 212 | 1,303 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 74 | 1982-02-15 | |
Ashish Vasavada
DFI | Director of Finance/CFO | 54 | 2021-10-20 |
Saurabh Mittal
COO | Chief Operating Officer | 41 | 2023-11-07 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 2015-02-22 | |
| Director/Board Member | 71 | 1982-02-15 | |
Paresh Mistry
BRD | Director/Board Member | 57 | 2017-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.78% | +6.16% | -3.29% | +6.29% | 10.51M | ||
| -1.51% | +1.10% | +58.11% | +15.62% | 315B | ||
| -0.99% | -3.50% | +22.91% | -10.98% | 67.81B | ||
| -0.27% | +1.80% | +38.56% | +82.01% | 9.23B | ||
| +0.34% | +0.51% | +5.21% | -1.87% | 8.56B | ||
| -3.27% | -6.80% | -25.44% | -5.88% | 4.18B | ||
| +0.12% | -11.96% | -7.91% | +16.33% | 3.59B | ||
| -2.26% | +1.02% | -47.58% | +21.10% | 3.55B | ||
| -0.27% | +1.12% | +44.09% | +56.22% | 2.79B | ||
| +3.79% | +1.33% | +7.85% | -21.52% | 2.09B | ||
| Average | -0.24% | -1.24% | +9.25% | +15.73% | 41.67B | |
| Weighted average by Cap. | -1.28% | +1.91% | +48.21% | +12.32% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 756M 7.84M 6.87M 6.35M 5.84M 11.02M 11.19M 75.91M 29.76M 370M 29.42M 28.78M 1.27B | 751M 7.79M 6.83M 6.31M 5.8M 10.95M 11.13M 75.45M 29.58M 367M 29.24M 28.61M 1.27B |
| Net income | 56.54M 586K 514K 475K 437K 824K 838K 5.68M 2.23M 27.67M 2.2M 2.15M 95.32M | 31.45M 326K 286K 264K 243K 459K 466K 3.16M 1.24M 15.39M 1.22M 1.2M 53.01M |
| Net Debt | -25.4M -263K -231K -213K -196K -370K -376K -2.55M -1M -12.43M -989K -968K -42.82M | 38.95M 404K 354K 327K 301K 568K 577K 3.91M 1.53M 19.06M 1.52M 1.48M 65.65M |
Employees
503
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | ₹858.80 | +1.78% | 101 |
| 26-07-17 | ₹843.75 | -3.79% | 163 |
| 26-07-16 | ₹876.95 | +10.18% | 1,825 |
| 26-07-15 | ₹795.90 | -1.74% | 22 |
| 26-07-14 | ₹810.00 | +1.22% | 10 |
- Stock Market
- Stocks
- MERCURYLAB6 Stock
Select your edition
All financial news and data tailored to specific country editions
















